NASDAQ:INO   Inovio Pharmaceuticals, Inc.
As a disclosure I am quite new to reading charts, but i have been learning. In this chart you can see that the consolidation of the highs and lows are funneling towards $13 a share. But keep in mind that a failing testing procedure can break the lows into a new support line. As the earnings are coming up, we may find a price rally.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.